Medical Care
Global Non-invasive Prenatal Genetic Testing Market Research Report 2025
- Mar 14, 25
- ID: 133512
- Pages: 75
- Figures: 78
- Views: 59
The global market for Non-invasive Prenatal Genetic Testing was valued at US$ 8419 million in the year 2024 and is projected to reach a revised size of US$ 20310 million by 2031, growing at a CAGR of 13.6% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Non-invasive Prenatal Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Prenatal Genetic Testing.
The Non-invasive Prenatal Genetic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-invasive Prenatal Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-invasive Prenatal Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Labcorp
Illumina
Roche
Natera
Premaitha Health
The Beijing Genomics Institute
Berry Genomics
Daan Gene
Annoroad
CapitalBio Technology
Segment by Type
NIPT Basic Edition
NIPT Plus
Segment by Application
Elderly Primipara
Assisted Reproductive Population
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-invasive Prenatal Genetic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Non-invasive Prenatal Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Prenatal Genetic Testing.
The Non-invasive Prenatal Genetic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-invasive Prenatal Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-invasive Prenatal Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Labcorp
Illumina
Roche
Natera
Premaitha Health
The Beijing Genomics Institute
Berry Genomics
Daan Gene
Annoroad
CapitalBio Technology
Segment by Type
NIPT Basic Edition
NIPT Plus
Segment by Application
Elderly Primipara
Assisted Reproductive Population
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-invasive Prenatal Genetic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NIPT Basic Edition
1.2.3 NIPT Plus
1.3 Market by Application
1.3.1 Global Non-invasive Prenatal Genetic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Elderly Primipara
1.3.3 Assisted Reproductive Population
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-invasive Prenatal Genetic Testing Market Perspective (2020-2031)
2.2 Global Non-invasive Prenatal Genetic Testing Growth Trends by Region
2.2.1 Global Non-invasive Prenatal Genetic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Non-invasive Prenatal Genetic Testing Historic Market Size by Region (2020-2025)
2.2.3 Non-invasive Prenatal Genetic Testing Forecasted Market Size by Region (2026-2031)
2.3 Non-invasive Prenatal Genetic Testing Market Dynamics
2.3.1 Non-invasive Prenatal Genetic Testing Industry Trends
2.3.2 Non-invasive Prenatal Genetic Testing Market Drivers
2.3.3 Non-invasive Prenatal Genetic Testing Market Challenges
2.3.4 Non-invasive Prenatal Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-invasive Prenatal Genetic Testing Players by Revenue
3.1.1 Global Top Non-invasive Prenatal Genetic Testing Players by Revenue (2020-2025)
3.1.2 Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Non-invasive Prenatal Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Non-invasive Prenatal Genetic Testing Revenue
3.4 Global Non-invasive Prenatal Genetic Testing Market Concentration Ratio
3.4.1 Global Non-invasive Prenatal Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Prenatal Genetic Testing Revenue in 2024
3.5 Global Key Players of Non-invasive Prenatal Genetic Testing Head office and Area Served
3.6 Global Key Players of Non-invasive Prenatal Genetic Testing, Product and Application
3.7 Global Key Players of Non-invasive Prenatal Genetic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-invasive Prenatal Genetic Testing Breakdown Data by Type
4.1 Global Non-invasive Prenatal Genetic Testing Historic Market Size by Type (2020-2025)
4.2 Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Type (2026-2031)
5 Non-invasive Prenatal Genetic Testing Breakdown Data by Application
5.1 Global Non-invasive Prenatal Genetic Testing Historic Market Size by Application (2020-2025)
5.2 Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Non-invasive Prenatal Genetic Testing Market Size (2020-2031)
6.2 North America Non-invasive Prenatal Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025)
6.4 North America Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-invasive Prenatal Genetic Testing Market Size (2020-2031)
7.2 Europe Non-invasive Prenatal Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025)
7.4 Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size (2020-2031)
8.2 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-invasive Prenatal Genetic Testing Market Size (2020-2031)
9.2 Latin America Non-invasive Prenatal Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025)
9.4 Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size (2020-2031)
10.2 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Labcorp
11.1.1 Labcorp Company Details
11.1.2 Labcorp Business Overview
11.1.3 Labcorp Non-invasive Prenatal Genetic Testing Introduction
11.1.4 Labcorp Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.1.5 Labcorp Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Non-invasive Prenatal Genetic Testing Introduction
11.2.4 Illumina Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.2.5 Illumina Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Non-invasive Prenatal Genetic Testing Introduction
11.3.4 Roche Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.3.5 Roche Recent Development
11.4 Natera
11.4.1 Natera Company Details
11.4.2 Natera Business Overview
11.4.3 Natera Non-invasive Prenatal Genetic Testing Introduction
11.4.4 Natera Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.4.5 Natera Recent Development
11.5 Premaitha Health
11.5.1 Premaitha Health Company Details
11.5.2 Premaitha Health Business Overview
11.5.3 Premaitha Health Non-invasive Prenatal Genetic Testing Introduction
11.5.4 Premaitha Health Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.5.5 Premaitha Health Recent Development
11.6 The Beijing Genomics Institute
11.6.1 The Beijing Genomics Institute Company Details
11.6.2 The Beijing Genomics Institute Business Overview
11.6.3 The Beijing Genomics Institute Non-invasive Prenatal Genetic Testing Introduction
11.6.4 The Beijing Genomics Institute Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.6.5 The Beijing Genomics Institute Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Non-invasive Prenatal Genetic Testing Introduction
11.7.4 Berry Genomics Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.7.5 Berry Genomics Recent Development
11.8 Daan Gene
11.8.1 Daan Gene Company Details
11.8.2 Daan Gene Business Overview
11.8.3 Daan Gene Non-invasive Prenatal Genetic Testing Introduction
11.8.4 Daan Gene Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.8.5 Daan Gene Recent Development
11.9 Annoroad
11.9.1 Annoroad Company Details
11.9.2 Annoroad Business Overview
11.9.3 Annoroad Non-invasive Prenatal Genetic Testing Introduction
11.9.4 Annoroad Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.9.5 Annoroad Recent Development
11.10 CapitalBio Technology
11.10.1 CapitalBio Technology Company Details
11.10.2 CapitalBio Technology Business Overview
11.10.3 CapitalBio Technology Non-invasive Prenatal Genetic Testing Introduction
11.10.4 CapitalBio Technology Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.10.5 CapitalBio Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NIPT Basic Edition
1.2.3 NIPT Plus
1.3 Market by Application
1.3.1 Global Non-invasive Prenatal Genetic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Elderly Primipara
1.3.3 Assisted Reproductive Population
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-invasive Prenatal Genetic Testing Market Perspective (2020-2031)
2.2 Global Non-invasive Prenatal Genetic Testing Growth Trends by Region
2.2.1 Global Non-invasive Prenatal Genetic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Non-invasive Prenatal Genetic Testing Historic Market Size by Region (2020-2025)
2.2.3 Non-invasive Prenatal Genetic Testing Forecasted Market Size by Region (2026-2031)
2.3 Non-invasive Prenatal Genetic Testing Market Dynamics
2.3.1 Non-invasive Prenatal Genetic Testing Industry Trends
2.3.2 Non-invasive Prenatal Genetic Testing Market Drivers
2.3.3 Non-invasive Prenatal Genetic Testing Market Challenges
2.3.4 Non-invasive Prenatal Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-invasive Prenatal Genetic Testing Players by Revenue
3.1.1 Global Top Non-invasive Prenatal Genetic Testing Players by Revenue (2020-2025)
3.1.2 Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Non-invasive Prenatal Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Non-invasive Prenatal Genetic Testing Revenue
3.4 Global Non-invasive Prenatal Genetic Testing Market Concentration Ratio
3.4.1 Global Non-invasive Prenatal Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Prenatal Genetic Testing Revenue in 2024
3.5 Global Key Players of Non-invasive Prenatal Genetic Testing Head office and Area Served
3.6 Global Key Players of Non-invasive Prenatal Genetic Testing, Product and Application
3.7 Global Key Players of Non-invasive Prenatal Genetic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-invasive Prenatal Genetic Testing Breakdown Data by Type
4.1 Global Non-invasive Prenatal Genetic Testing Historic Market Size by Type (2020-2025)
4.2 Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Type (2026-2031)
5 Non-invasive Prenatal Genetic Testing Breakdown Data by Application
5.1 Global Non-invasive Prenatal Genetic Testing Historic Market Size by Application (2020-2025)
5.2 Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Non-invasive Prenatal Genetic Testing Market Size (2020-2031)
6.2 North America Non-invasive Prenatal Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025)
6.4 North America Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-invasive Prenatal Genetic Testing Market Size (2020-2031)
7.2 Europe Non-invasive Prenatal Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025)
7.4 Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size (2020-2031)
8.2 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-invasive Prenatal Genetic Testing Market Size (2020-2031)
9.2 Latin America Non-invasive Prenatal Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025)
9.4 Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size (2020-2031)
10.2 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Labcorp
11.1.1 Labcorp Company Details
11.1.2 Labcorp Business Overview
11.1.3 Labcorp Non-invasive Prenatal Genetic Testing Introduction
11.1.4 Labcorp Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.1.5 Labcorp Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Non-invasive Prenatal Genetic Testing Introduction
11.2.4 Illumina Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.2.5 Illumina Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Non-invasive Prenatal Genetic Testing Introduction
11.3.4 Roche Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.3.5 Roche Recent Development
11.4 Natera
11.4.1 Natera Company Details
11.4.2 Natera Business Overview
11.4.3 Natera Non-invasive Prenatal Genetic Testing Introduction
11.4.4 Natera Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.4.5 Natera Recent Development
11.5 Premaitha Health
11.5.1 Premaitha Health Company Details
11.5.2 Premaitha Health Business Overview
11.5.3 Premaitha Health Non-invasive Prenatal Genetic Testing Introduction
11.5.4 Premaitha Health Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.5.5 Premaitha Health Recent Development
11.6 The Beijing Genomics Institute
11.6.1 The Beijing Genomics Institute Company Details
11.6.2 The Beijing Genomics Institute Business Overview
11.6.3 The Beijing Genomics Institute Non-invasive Prenatal Genetic Testing Introduction
11.6.4 The Beijing Genomics Institute Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.6.5 The Beijing Genomics Institute Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Non-invasive Prenatal Genetic Testing Introduction
11.7.4 Berry Genomics Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.7.5 Berry Genomics Recent Development
11.8 Daan Gene
11.8.1 Daan Gene Company Details
11.8.2 Daan Gene Business Overview
11.8.3 Daan Gene Non-invasive Prenatal Genetic Testing Introduction
11.8.4 Daan Gene Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.8.5 Daan Gene Recent Development
11.9 Annoroad
11.9.1 Annoroad Company Details
11.9.2 Annoroad Business Overview
11.9.3 Annoroad Non-invasive Prenatal Genetic Testing Introduction
11.9.4 Annoroad Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.9.5 Annoroad Recent Development
11.10 CapitalBio Technology
11.10.1 CapitalBio Technology Company Details
11.10.2 CapitalBio Technology Business Overview
11.10.3 CapitalBio Technology Non-invasive Prenatal Genetic Testing Introduction
11.10.4 CapitalBio Technology Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025)
11.10.5 CapitalBio Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NIPT Basic Edition
Table 3. Key Players of NIPT Plus
Table 4. Global Non-invasive Prenatal Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Non-invasive Prenatal Genetic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Non-invasive Prenatal Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Non-invasive Prenatal Genetic Testing Market Share by Region (2020-2025)
Table 8. Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Non-invasive Prenatal Genetic Testing Market Share by Region (2026-2031)
Table 10. Non-invasive Prenatal Genetic Testing Market Trends
Table 11. Non-invasive Prenatal Genetic Testing Market Drivers
Table 12. Non-invasive Prenatal Genetic Testing Market Challenges
Table 13. Non-invasive Prenatal Genetic Testing Market Restraints
Table 14. Global Non-invasive Prenatal Genetic Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Non-invasive Prenatal Genetic Testing Market Share by Players (2020-2025)
Table 16. Global Top Non-invasive Prenatal Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Prenatal Genetic Testing as of 2024)
Table 17. Ranking of Global Top Non-invasive Prenatal Genetic Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Non-invasive Prenatal Genetic Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Non-invasive Prenatal Genetic Testing, Headquarters and Area Served
Table 20. Global Key Players of Non-invasive Prenatal Genetic Testing, Product and Application
Table 21. Global Key Players of Non-invasive Prenatal Genetic Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non-invasive Prenatal Genetic Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Non-invasive Prenatal Genetic Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Labcorp Company Details
Table 47. Labcorp Business Overview
Table 48. Labcorp Non-invasive Prenatal Genetic Testing Product
Table 49. Labcorp Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 50. Labcorp Recent Development
Table 51. Illumina Company Details
Table 52. Illumina Business Overview
Table 53. Illumina Non-invasive Prenatal Genetic Testing Product
Table 54. Illumina Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 55. Illumina Recent Development
Table 56. Roche Company Details
Table 57. Roche Business Overview
Table 58. Roche Non-invasive Prenatal Genetic Testing Product
Table 59. Roche Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Natera Company Details
Table 62. Natera Business Overview
Table 63. Natera Non-invasive Prenatal Genetic Testing Product
Table 64. Natera Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 65. Natera Recent Development
Table 66. Premaitha Health Company Details
Table 67. Premaitha Health Business Overview
Table 68. Premaitha Health Non-invasive Prenatal Genetic Testing Product
Table 69. Premaitha Health Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 70. Premaitha Health Recent Development
Table 71. The Beijing Genomics Institute Company Details
Table 72. The Beijing Genomics Institute Business Overview
Table 73. The Beijing Genomics Institute Non-invasive Prenatal Genetic Testing Product
Table 74. The Beijing Genomics Institute Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 75. The Beijing Genomics Institute Recent Development
Table 76. Berry Genomics Company Details
Table 77. Berry Genomics Business Overview
Table 78. Berry Genomics Non-invasive Prenatal Genetic Testing Product
Table 79. Berry Genomics Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 80. Berry Genomics Recent Development
Table 81. Daan Gene Company Details
Table 82. Daan Gene Business Overview
Table 83. Daan Gene Non-invasive Prenatal Genetic Testing Product
Table 84. Daan Gene Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 85. Daan Gene Recent Development
Table 86. Annoroad Company Details
Table 87. Annoroad Business Overview
Table 88. Annoroad Non-invasive Prenatal Genetic Testing Product
Table 89. Annoroad Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 90. Annoroad Recent Development
Table 91. CapitalBio Technology Company Details
Table 92. CapitalBio Technology Business Overview
Table 93. CapitalBio Technology Non-invasive Prenatal Genetic Testing Product
Table 94. CapitalBio Technology Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 95. CapitalBio Technology Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Non-invasive Prenatal Genetic Testing Picture
Figure 2. Global Non-invasive Prenatal Genetic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Non-invasive Prenatal Genetic Testing Market Share by Type: 2024 VS 2031
Figure 4. NIPT Basic Edition Features
Figure 5. NIPT Plus Features
Figure 6. Global Non-invasive Prenatal Genetic Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Non-invasive Prenatal Genetic Testing Market Share by Application: 2024 VS 2031
Figure 8. Elderly Primipara Case Studies
Figure 9. Assisted Reproductive Population Case Studies
Figure 10. Others Case Studies
Figure 11. Non-invasive Prenatal Genetic Testing Report Years Considered
Figure 12. Global Non-invasive Prenatal Genetic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Non-invasive Prenatal Genetic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Non-invasive Prenatal Genetic Testing Market Share by Region: 2024 VS 2031
Figure 15. Global Non-invasive Prenatal Genetic Testing Market Share by Players in 2024
Figure 16. Global Top Non-invasive Prenatal Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Prenatal Genetic Testing as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Non-invasive Prenatal Genetic Testing Revenue in 2024
Figure 18. North America Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Non-invasive Prenatal Genetic Testing Market Share by Country (2020-2031)
Figure 20. United States Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Non-invasive Prenatal Genetic Testing Market Share by Country (2020-2031)
Figure 24. Germany Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Share by Region (2020-2031)
Figure 32. China Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Non-invasive Prenatal Genetic Testing Market Share by Country (2020-2031)
Figure 40. Mexico Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Share by Country (2020-2031)
Figure 44. Turkey Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Labcorp Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 48. Illumina Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 49. Roche Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 50. Natera Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 51. Premaitha Health Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 52. The Beijing Genomics Institute Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 53. Berry Genomics Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 54. Daan Gene Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 55. Annoroad Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 56. CapitalBio Technology Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NIPT Basic Edition
Table 3. Key Players of NIPT Plus
Table 4. Global Non-invasive Prenatal Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Non-invasive Prenatal Genetic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Non-invasive Prenatal Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Non-invasive Prenatal Genetic Testing Market Share by Region (2020-2025)
Table 8. Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Non-invasive Prenatal Genetic Testing Market Share by Region (2026-2031)
Table 10. Non-invasive Prenatal Genetic Testing Market Trends
Table 11. Non-invasive Prenatal Genetic Testing Market Drivers
Table 12. Non-invasive Prenatal Genetic Testing Market Challenges
Table 13. Non-invasive Prenatal Genetic Testing Market Restraints
Table 14. Global Non-invasive Prenatal Genetic Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Non-invasive Prenatal Genetic Testing Market Share by Players (2020-2025)
Table 16. Global Top Non-invasive Prenatal Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Prenatal Genetic Testing as of 2024)
Table 17. Ranking of Global Top Non-invasive Prenatal Genetic Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Non-invasive Prenatal Genetic Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Non-invasive Prenatal Genetic Testing, Headquarters and Area Served
Table 20. Global Key Players of Non-invasive Prenatal Genetic Testing, Product and Application
Table 21. Global Key Players of Non-invasive Prenatal Genetic Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non-invasive Prenatal Genetic Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Non-invasive Prenatal Genetic Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Non-invasive Prenatal Genetic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Labcorp Company Details
Table 47. Labcorp Business Overview
Table 48. Labcorp Non-invasive Prenatal Genetic Testing Product
Table 49. Labcorp Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 50. Labcorp Recent Development
Table 51. Illumina Company Details
Table 52. Illumina Business Overview
Table 53. Illumina Non-invasive Prenatal Genetic Testing Product
Table 54. Illumina Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 55. Illumina Recent Development
Table 56. Roche Company Details
Table 57. Roche Business Overview
Table 58. Roche Non-invasive Prenatal Genetic Testing Product
Table 59. Roche Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Natera Company Details
Table 62. Natera Business Overview
Table 63. Natera Non-invasive Prenatal Genetic Testing Product
Table 64. Natera Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 65. Natera Recent Development
Table 66. Premaitha Health Company Details
Table 67. Premaitha Health Business Overview
Table 68. Premaitha Health Non-invasive Prenatal Genetic Testing Product
Table 69. Premaitha Health Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 70. Premaitha Health Recent Development
Table 71. The Beijing Genomics Institute Company Details
Table 72. The Beijing Genomics Institute Business Overview
Table 73. The Beijing Genomics Institute Non-invasive Prenatal Genetic Testing Product
Table 74. The Beijing Genomics Institute Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 75. The Beijing Genomics Institute Recent Development
Table 76. Berry Genomics Company Details
Table 77. Berry Genomics Business Overview
Table 78. Berry Genomics Non-invasive Prenatal Genetic Testing Product
Table 79. Berry Genomics Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 80. Berry Genomics Recent Development
Table 81. Daan Gene Company Details
Table 82. Daan Gene Business Overview
Table 83. Daan Gene Non-invasive Prenatal Genetic Testing Product
Table 84. Daan Gene Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 85. Daan Gene Recent Development
Table 86. Annoroad Company Details
Table 87. Annoroad Business Overview
Table 88. Annoroad Non-invasive Prenatal Genetic Testing Product
Table 89. Annoroad Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 90. Annoroad Recent Development
Table 91. CapitalBio Technology Company Details
Table 92. CapitalBio Technology Business Overview
Table 93. CapitalBio Technology Non-invasive Prenatal Genetic Testing Product
Table 94. CapitalBio Technology Revenue in Non-invasive Prenatal Genetic Testing Business (2020-2025) & (US$ Million)
Table 95. CapitalBio Technology Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Non-invasive Prenatal Genetic Testing Picture
Figure 2. Global Non-invasive Prenatal Genetic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Non-invasive Prenatal Genetic Testing Market Share by Type: 2024 VS 2031
Figure 4. NIPT Basic Edition Features
Figure 5. NIPT Plus Features
Figure 6. Global Non-invasive Prenatal Genetic Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Non-invasive Prenatal Genetic Testing Market Share by Application: 2024 VS 2031
Figure 8. Elderly Primipara Case Studies
Figure 9. Assisted Reproductive Population Case Studies
Figure 10. Others Case Studies
Figure 11. Non-invasive Prenatal Genetic Testing Report Years Considered
Figure 12. Global Non-invasive Prenatal Genetic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Non-invasive Prenatal Genetic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Non-invasive Prenatal Genetic Testing Market Share by Region: 2024 VS 2031
Figure 15. Global Non-invasive Prenatal Genetic Testing Market Share by Players in 2024
Figure 16. Global Top Non-invasive Prenatal Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Prenatal Genetic Testing as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Non-invasive Prenatal Genetic Testing Revenue in 2024
Figure 18. North America Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Non-invasive Prenatal Genetic Testing Market Share by Country (2020-2031)
Figure 20. United States Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Non-invasive Prenatal Genetic Testing Market Share by Country (2020-2031)
Figure 24. Germany Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Non-invasive Prenatal Genetic Testing Market Share by Region (2020-2031)
Figure 32. China Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Non-invasive Prenatal Genetic Testing Market Share by Country (2020-2031)
Figure 40. Mexico Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Share by Country (2020-2031)
Figure 44. Turkey Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Non-invasive Prenatal Genetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Labcorp Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 48. Illumina Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 49. Roche Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 50. Natera Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 51. Premaitha Health Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 52. The Beijing Genomics Institute Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 53. Berry Genomics Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 54. Daan Gene Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 55. Annoroad Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 56. CapitalBio Technology Revenue Growth Rate in Non-invasive Prenatal Genetic Testing Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232